Showing results (41-50 of 113) with videos related to

Sort By:
Pageof 12
Drug Testing and Analysis|October 6, 2016
Discordant genotyping results using DNA isolated from anti-doping control urine samplesEva Choong, Jenny J Schulze, Magnus Ericsson, et al.
Substance Abuse Treatment, Prevention, and Policy|March 7, 2016
Recruitment to doping and help-seeking behavior of eight female AAS usersAnnica Börjesson, Nina Gårevik, Marja-Liisa Dahl, et al.
Biochemical and Biophysical Research Communications|January 18, 2005
Biosynthesis of epoxyeicosatrienoic acids varies between polymorphic CYP2C enzymesMia Sandberg Lundblad, Katarina Stark, Erik Eliasson, et al.
Pharmacogenetics and Genomics|March 9, 2011
Bioavailability of testosterone enanthate dependent on genetic variation in the phosphodiesterase 7B but not on the uridine 5'-diphospho-glucuronosyltransferase (UGT2B17) geneLena Ekström, Jenny J Schulze, Chantal Guillemette, et al.
European Journal of Clinical Pharmacology|September 19, 2003
The anti-doping hot-line, a means to capture the abuse of doping agents in the Swedish society and a new service function in clinical pharmacologyAnn-Charlotte Eklöf, Ann-Mari Thurelius, Mats Garle, et al.
Basic & Clinical Pharmacology & Toxicology|November 10, 2015
The Role of CYP2C8 and CYP2C9 Genotypes in Losartan-Dependent Inhibition of Paclitaxel Metabolism in Human Liver MicrosomesYuji Mukai, Asuna Senda, Takaki Toda, et al.
Heart and Vessels|January 8, 2011
Beneficial vasoactive endothelial effects of fluvastatin: focus on prostacyclin and nitric oxideCristine Skogastierna, Leonid Luksha, Karolina Kublickiene, et al.
Biological & Pharmaceutical Bulletin|September 2, 2014
Losartan competitively inhibits CYP2C8-dependent paclitaxel metabolism in vitroYuji Mukai, Takaki Toda, Toru Hayakawa, et al.
The Journal of Biological Chemistry|June 7, 2005
A novel polymorphic cytochrome P450 formed by splicing of CYP3A7 and the pseudogene CYP3AP1Cristina Rodriguez-Antona, Magnus Axelson, Charlotta Otter, et al.
Journal of Thrombosis and Thrombolysis|May 22, 2007
Incidence and predictors of severe bleeding during warfarin treatmentJonatan D Lindh, Lennart Holm, Marja-Liisa Dahl, et al.
Pageof 12